A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults
Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavrin;   Drug: Pegylated Interferon alpha 2-alpha (PegINF);   Drug: TelaprevirSponsor:   AbbVieActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2013 Category: Research Source Type: clinical trials

Interaction Between Paroxetine and Telaprevir
Conditions:   Hepatitis C Infection;   DepressionInterventions:   Drug: Paroxetine;   Drug: telaprevirSponsors:   Radboud University;   Janssen, LPTerminated - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated Interferon alpha 2-alpha (PegIFN)Sponsor:   AbbVieActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated Interferon alpha 2-alpha (PegIFN)Sponsor:   AbbVieActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2013 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
Condition:   Chronic Hepatitis C InfectionInterventions:   Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin;   Drug: Telaprevir;   Drug: Pegylated Interferon alpha 2-alpha (PegIFN)Sponsor:   AbbVieActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2013 Category: Research Source Type: clinical trials

Interaction Between Paroxetine and Telaprevir
Conditions:   Hepatitis C Infection;   DepressionInterventions:   Drug: Paroxetine;   Drug: telaprevirSponsors:   Radboud University;   Janssen, LPRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2013 Category: Research Source Type: clinical trials